BHVN — Biohaven Pharmaceutical Holding Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousLarge CapMomentum Trap
- $10.52bn
- $11.30bn
- $462.51m
Annual cashflow statement for Biohaven Pharmaceutical Holding, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -127 | -241 | -529 | -769 | -848 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 31.8 | 37 | 111 | 163 | 209 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.583 | 6.79 | 41 | -107 | -217 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -94.8 | -197 | -377 | -703 | -831 |
| Capital Expenditures | -0.541 | -4.17 | -2.53 | -43.9 | -1.72 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -6.5 | -6.38 | -1.25 | -226 | 28.3 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -7.04 | -10.5 | -3.78 | -270 | 26.6 |
| Financing Cash Flow Items | -5.66 | 103 | -1.15 | 205 | 100 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 210 | 340 | 435 | 789 | 845 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 108 | 133 | 53.5 | -183 | 40.1 |